Articles tagged with: Gene Therapy
As The Beacon continues its ‘ASH Preview’ series about myeloma research that will be presented at the American Society of Hematology (ASH) meeting in early December, this article focuses on novel immunotherapy approaches that are being studied in clinical trials.
Abstracts for the ASH presentations are now available, although many contain preliminary information that will be updated at the meeting.
The Beacon’s ASH preview articles are intended to highlight the meeting’s most interesting myeloma-related studies.
The first several of the preview articles, which were published over …
One of The Myeloma Beacon’s most popular news stories of 2011 reported on an important new development in the use of gene therapy to treat blood cancers.
In particular, the article described promising results from a small study using gene therapy to treat patients who have chronic lymphocytic leukemia (CLL), and it looked at how those results might translate into new therapies for multiple myeloma (see related Beacon news).
Since the results of the CLL study were made public last year, follow-up results and additional ongoing studies …
A promising experimental method for treating advanced leukemia may point the way to important new treatment options for multiple myeloma.
“It is very exciting,” said Dr. Leif Bergsagel, a myeloma specialist from the Mayo Clinic in Arizona who was not involved in the study investigating the leukemia treatment. “I think this approach could and should be extended to multiple myeloma.” He pointed out, however, that “It will be several years before myeloma patients will be treated this way.”
In two recently published research articles, scientists from the University of Pennsylvania described initial results of a pilot study they are conducting. …